'Deep dive' into biology of kidney tumors identifies markers of response to immunotherapy

(Memorial Sloan Kettering Cancer Center) An international team of investigators led by Memorial Sloan Kettering's Robert Motzer has identified biological attributes of kidney cancer tumors that correlate with better responses to immunotherapies and targeted therapies.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news